This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Petrovich GD, Ross CA, Holland PC, Gallagher M . J Neurosci 2007; 27: 6436–6441.
Tataranni PA, Gautier J-F, Chen K, Uecker A, Bandy D, Salbe AD et al. Proc Natt Acad Sci USA 1999; 96: 4569–4574.
Everitt BJ, Robbins TW . Annu Rev Psychol 1997; 48: 649–684.
Tzavara ET, Bymaster FP, Overshiner CD, Davis RJ, Perry KW, Wolff M et al. Mol Psychiatry 2006; 11: 187–195.
Bazar KA, Yun AJ, Lee PY, Daniel SM, Doux JD . Med Hypotheses 2006; 66: 263–269.
Alonso-Alonso M, Pascual-Leone A . JAMA 2007; 297: 1819–1822.
Hofbauer KG, Nicholson JR, Boss O . Annu Rev Pharmacol Toxicol 2007; 47: 565–592.
Tzavara ET, Davis RJ, Perry KW, Li X, Salhoff C, Bymaster FP et al. Br J Pharmacol 2003; 138: 544–553.
Degroot A, Kofalvi A, Wade MR, Davis RJ, Rodrigues RJ, Rebola N et al. Mol Pharmacol 2006; 70: 1236–1245.
Gundlah C, Martin KF, Heal DJ, Auerbach SB . J Pharmacol Exp Ther 1997; 283: 581–591.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Davis, R., Nomikos, G. Oral administration of the antiobesity drugs, sibutramine and rimonabant, increases acetylcholine efflux selectively in the medial prefrontal cortex of the rat. Mol Psychiatry 13, 240–241 (2008). https://doi.org/10.1038/sj.mp.4002112
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.mp.4002112